FORTH MARC (Chief Executive Officer) received a stock award from AEON BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/4/2024ACC: 0001104659-24-097067
DirectorOfficer· Chief Executive Officer
Since Jul 2023
+1.73M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.73M acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+470.69K
Price / share
—
Trade value
—
% of position
168.2%
8/31/2024
279.86K→750.55K
Total
Net shares
+470.69K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/31/2024 | A · Award | +470.69K | — | — | 168.2% | 279.86K | 750.55K |
| Total | +470.69K | $0.00 | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Class A Common Stock
1.26M shares
Shares
+1.26M
Strike price
0.83
Held after
1.26M
Exercisable
—
8/31/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Class A Common Stock1.26M shares | 8/31/2024 | A · Award | +1.26M | 0.83 | — | 1.26M |